Biodexa Pharmaceuticals Plc (BDRX)
0.9474
+0.01
(+0.79%)
USD |
NASDAQ |
Mar 05, 16:00
0.9473
0.00 (0.00%)
After-Hours: 07:54
Biodexa Pharmaceuticals Cash from Investing (TTM) : -0.4065M for June 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| NuCana Plc | -0.2609M |
| Autolus Therapeutics Plc | -311.41M |
| Mereo BioPharma Group Plc | -0.0172M |
| Bicycle Therapeutics Plc | -2.147M |
| DBV Technologies SA | 0.1363M |